Erasca, Inc. (ERAS)
NASDAQ: ERAS · IEX Real-Time Price · USD
2.950
-0.070 (-2.32%)
At close: Jul 19, 2024, 4:00 PM
3.030
+0.080 (2.71%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $766.54 million as of July 22, 2024. Its market cap has increased by 89.74% in one year.
Market Cap
766.54M
Enterprise Value
523.39M
1-Year Change
89.74%
Ranking
Category
Stock Price
$2.95
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has decreased from $1.86B to $766.54M, a decrease of -58.75%. That is a compound annual growth rate of -25.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 511.40M | 58.92% |
| Dec 29, 2023 | 321.80M | -38.98% |
| Dec 30, 2022 | 527.40M | -72.08% |
| Dec 31, 2021 | 1.89B | 1.66% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 795.19M |
| Simulations Plus | 791.10M |
| Abivax | 780.18M |
| Dianthus Therapeutics | 779.52M |
| OrthoPediatrics | 776.11M |
| Embecta | 759.52M |
| Phibro Animal Health | 754.99M |
| Evolus | 748.82M |